Oregon Health and Science University

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Effects of Stress-reducing Aromatherapy

Phase 2
Completed
Conditions
Interventions
First Posted Date
2011-03-03
Last Posted Date
2019-08-19
Lead Sponsor
Oregon Health and Science University
Target Recruit Count
92
Registration Number
NCT01307748
Locations
🇺🇸

Oregon Health & Science University, Portland, Oregon, United States

Targeted Screening for Taenia Solium Tapeworms

First Posted Date
2011-02-16
Last Posted Date
2014-10-24
Lead Sponsor
Oregon Health and Science University
Target Recruit Count
1811
Registration Number
NCT01296958
Locations
🇵🇪

San Marcos University, Lima, Peru

Microvascular and Cardiac Dysfunction in Paroxysmal Nocturnal Hemoglobinuria and Sickle Cell Disease

First Posted Date
2011-02-14
Last Posted Date
2014-10-28
Lead Sponsor
Oregon Health and Science University
Target Recruit Count
6
Registration Number
NCT01294891
Locations
🇺🇸

Oregon Health & Science University, Portland, Oregon, United States

Lipoic Acid as a Treatment for Acute Optic Neuritis

Phase 1
Completed
Conditions
Interventions
First Posted Date
2011-02-11
Last Posted Date
2019-04-26
Lead Sponsor
Oregon Health and Science University
Target Recruit Count
31
Registration Number
NCT01294176
Locations
🇺🇸

Oregon Health & Science University, Portland, Oregon, United States

The Effects of Emollient Therapy on the Skin Barrier

First Posted Date
2011-02-09
Last Posted Date
2019-07-15
Lead Sponsor
Oregon Health and Science University
Target Recruit Count
25
Registration Number
NCT01291940
Locations
🇺🇸

Oregon Health & Science University Center for Health & Healing, Portland, Oregon, United States

Safety & Health Improvement: Enhancing Law Enforcement Departments

First Posted Date
2011-01-20
Last Posted Date
2015-10-30
Lead Sponsor
Oregon Health and Science University
Target Recruit Count
489
Registration Number
NCT01279941
Locations
🇺🇸

Oregon Health and Science University, Portland, Oregon, United States

Abatacept in the Treatment of Uveitis

Phase 2
Completed
Conditions
Interventions
First Posted Date
2011-01-20
Last Posted Date
2019-02-21
Lead Sponsor
Oregon Health and Science University
Target Recruit Count
10
Registration Number
NCT01279954
Locations
🇺🇸

Oregon Health & Science University, Portland, Oregon, United States

Infliximab, Regulatory T Cells, IL2 and Crohn's Disease

Not Applicable
Withdrawn
Conditions
First Posted Date
2010-12-24
Last Posted Date
2019-05-08
Lead Sponsor
Oregon Health and Science University
Registration Number
NCT01266785
Locations
🇺🇸

Oregon Health & Science University, Portland, Oregon, United States

Medical Therapy Versus Sinus Surgery for Chronic Rhinosinusitis: A Prospective, Multi-institutional Study

First Posted Date
2010-12-07
Last Posted Date
2013-04-24
Lead Sponsor
Oregon Health and Science University
Target Recruit Count
186
Registration Number
NCT01255566
Locations
🇺🇸

Medical University of South Carolina, Charleston, South Carolina, United States

🇺🇸

University of Pennsylvania, Philadelphia, Pennsylvania, United States

🇺🇸

Northwestern University, Chicago, Illinois, United States

Oral Steroid Treatment for Chronic Rhinosinusitis

First Posted Date
2010-12-07
Last Posted Date
2015-04-22
Lead Sponsor
Oregon Health and Science University
Registration Number
NCT01255683
Locations
🇺🇸

Oregon Health & Science University, Portland, Oregon, United States

© Copyright 2024. All Rights Reserved by MedPath